Ascertain provides AI agents designed to automate complex healthcare administrative workflows, including prior authorization, eligibility verification, and referral processing. The platform ingests unstructured data to automate form completion and reliably communicate results, significantly lowering administrative costs. By integrating seamlessly with existing systems, Ascertain empowers clinical staff to reduce repetitive tasks and focus more time on direct patient care.

Cohere Health utilizes the Cohere Unify™ Platform, which employs artificial intelligence and machine learning to automate the prior authorization process, integrating with electronic medical records for streamlined workflows. The platform addresses delays in patient care access and high denial rates by digitizing requests and providing evidence-based decision support, resulting in faster approvals and improved clinical outcomes.

CURE Finance provides specialized online banking and financial management software tailored for medical and dental practices. The platform automatically categorizes transactions, offers real-time liquidity analysis, and generates key performance indicators to improve practice profitability. Users gain financial transparency and AI-driven optimization tips to better control cash flow and make informed fiscal decisions.

The startup provides clinical research and development services focused on enhancing Amphotericin B to treat systemic and life-threatening fungal infections. Their approach enables the delivery of a broad spectrum of non-toxic antifungal drugs, improving patient safety and treatment efficacy.

Intus Care is a healthcare analytics platform that utilizes data synthesis and predictive modeling to identify patients at high risk for hospitalizations and chronic diseases. By enabling care providers to visualize trends and make data-driven decisions, the platform enhances operational efficiency and reduces overall healthcare expenditures.

Nema Health provides a fully virtual, intensive trauma treatment program based on Cognitive Processing Therapy, delivering 12 structured therapist sessions over 4–6 weeks with optional long‑term follow‑up care. The service connects patients with licensed, PTSD‑specialized therapists, offers peer navigator support, and is in‑network with major insurers, enabling rapid, evidence‑based treatment for trauma survivors across multiple U.S. states.

Pairwise utilizes CRISPR gene editing technology to develop unique crop varieties, such as seedless blackberries and pitless cherries, that enhance consumer convenience and agricultural sustainability. The company addresses the challenges of resource-intensive supply chains and climate adaptability in food production by delivering higher-yielding, resilient crops.

Petfolk offers in-person and virtual veterinary services, utilizing online scheduling and 24/7 medical chat to provide immediate access to care. The startup addresses the need for convenient and high-quality pet healthcare by combining expert veterinary knowledge with modern technology in welcoming environments.

Pleno has developed the RAPTOR Hypercoding platform, which enables rapid genomic testing from a single patient sample, delivering results within the same day. This technology addresses the high costs and lengthy workflows associated with traditional genomic testing methods, making advanced diagnostics more accessible and economically viable for clinical labs.

R3 Vascular develops bioresorbable polymer scaffolds using a proprietary manufacturing process to treat peripheral artery disease. These scaffolds provide a temporary support structure that promotes vascular healing while gradually resorbing, addressing the need for effective and less invasive treatment options.

Synthekine is developing selective cytokine therapies using cytokine partial agonists, orthogonal cytokine and cell therapies, and surrogate cytokine agonists to enhance treatment efficacy for cancer and autoimmune diseases. The company addresses the limitations of current cytokine therapeutics by engineering solutions that minimize pleiotropy and improve therapeutic specificity.